Attenuation of EMT in RPE cells and subretinal fibrosis by an RAR-γ agonist
- 1.4k Downloads
Subretinal fibrosis contributes to the loss of vision associated with age-related macular degeneration (AMD). Retinal pigment epithelial (RPE) cells play a key role in the pathogenesis of AMD including the fibrotic reaction. We examined the role of retinoic acid receptor-γ (RAR-γ) in the epithelial-mesenchymal transition (EMT) and other fibrosis-related processes in mouse RPE cells cultured in a type I collagen gel. Transforming growth factor-β2 (TGF-β2)–induced collagen gel contraction mediated by the RPE cells was inhibited by the RAR-γ agonist R667 in a concentration- and time-dependent manner. Expression of the mesenchymal markers α-smooth muscle actin and fibronectin, the release of interleukin-6, and the phosphorylation of paxillin, mitogen-activated protein kinases (ERK, p38, and JNK), Smad2, and AKT induced by TGF-β2 were also suppressed by the RAR-γ agonist. Furthermore, gelatin zymography and immunoblot analysis revealed that the TGF-β2-induced release of matrix metalloproteinase (MMP)-2, MMP-3, MMP-8, and MMP-9 from RPE cells was inhibited by R667, and the MMP inhibitor GM6001 attenuated TGF-β2-induced RPE cell contraction. Finally, immunohistofluorescence analysis with antibodies to glial fibrillary acidic protein showed that R667 inhibited the development of subretinal fibrosis in a mouse model in vivo. Our results thus suggest that RAR-γ agonists may prove effective for the treatment of subretinal fibrosis associated with AMD.
RAR-γ agonist R667 suppressed collagen gel contraction mediated by RPE cells.
Epithelial-mesenchymal transition (EMT) in RPE cells was inhibited by RAR-γ agonist R667.
RAR-γ agonist R667 inhibited fibrosis-related processes in RPE cells.
RAR-γ agonists may attenuate AMD-associated fibrosis.
KeywordsRetinal pigment epithelial cell Transforming growth factor-β (TGF-β) Epithelial-mesenchymal transition Extracellular matrix Subretinal fibrosis Age-related macular degeneration
This study was supported by Takeda Science Foundation. We thank Yukari Mizuno and Shizuka Murata for technical assistance.
The authors declare no conflicts of interest.
- 13.Jo YJ, Sonoda KH, Oshima Y, Takeda A, Kohno R, Yamada J, Hamuro J, Yang Y, Notomi S, Hisatomi T et al (2011) Establishment of a new animal model of focal subretinal fibrosis that resembles disciform lesion in advanced age-related macular degeneration. Invest Ophthalmol Vis Sci 52:6089–6095PubMedCrossRefGoogle Scholar
- 21.Kischer CW, Shetlar MR, Chvapil M (1982) Hypertrophic scars and keloids: a review and new concept concerning their origin. Scan Electron Microsc :1699–1713Google Scholar
- 22.Hammer M, Konigsdorffer E, Liebermann C, Framme C, Schuch G, Schweitzer D, Strobel J (2008) Ocular fundus auto-fluorescence observations at different wavelengths in patients with age-related macular degeneration and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 246:105–114PubMedCrossRefGoogle Scholar
- 40.Thomas PE, Peters-Golden M, White ES, Thannickal VJ, Moore BB (2007) PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling. Am J Physiol Lung Cell Mol Physiol 293:L417–L428PubMedCentralPubMedCrossRefGoogle Scholar